Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Strickler

Showing results (31-40 of 100) with videos related to

Pageof 10
Sort By:
The Oncologist|July 18, 2023
Impact of Anti-EGFR Therapies on HER2-Positive Metastatic Colorectal Cancer: A Systematic Literature Review and Meta-Analysis of Clinical OutcomesTanios S Bekaii-Saab, Krzysztof Lach, Ling-I Hsu, et al.
Cancer Chemotherapy and Pharmacology|February 16, 2022
Cabozantinib with or without Panitumumab for RAS wild-type metastatic colorectal cancer: impact of MET amplification on clinical outcomes and circulating biomarkersJingquan Jia, Lauren Howard, Yingmiao Liu, et al.
Hematology Reports|October 25, 2024
Comprehensive Genomic Profiling in Non-Myeloid Hematologic Malignancies Identifies Variants That Can Alter Clinical PracticeChenyu Lin, Katherine I Zhou, Michelle F Green, et al.
Journal of Gastrointestinal Cancer|December 9, 2024
A Phase 2 study of Savolitinib in Patients with MET Amplified Metastatic Colorectal CancerJingquan Jia, Ashley Moyer, Melissa Lowe, et al.
Cancer|December 11, 2025
Pembrolizumab, Radiotherapy, and Chemotherapy in Neoadjuvant Treatment of Malignant Esophago-gastric Diseases (PROCEED): A single-arm phase 2 trialPooja Karukonda, Brian G Czito, Eileen Duffy, et al.
Clinical Lung Cancer|May 11, 2021
Predictive Value of Combining Biomarkers for Clinical Outcomes in Advanced Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint InhibitorsChester Kao, Eric Powers, Yuan Wu, et al.
Future Oncology (London, England)|August 3, 2022
Efficacy and safety of dilpacimab (ABT-165) versus bevacizumab plus FOLFIRI in metastatic colorectal cancer: a phase II studyJohn H Strickler, Antonio Cubillo, Jin-Tung Liang, et al.
Surgery|May 14, 2023
Hepatic artery infusion for unresectable colorectal cancer liver metastases: Palliation and conversionMohammad Y Zaidi, Daniel P Nussbaum, Shiaowen David Hsu, et al.
Cancer Research Communications|October 23, 2024
Association of Race and Ethnicity with Genomic Testing at a Comprehensive Cancer Center in North CarolinaClare Meernik, Frances Wang, Yadurshini Raveendran, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 13, 2019
Adjuvant Chemotherapy Improves Survival Following Resection of Locally Advanced Rectal Cancer with Pathologic Complete ResponseMegan C Turner, Jeffrey E Keenan, Christel N Rushing, et al.
Pageof 10

Showing results (31-40 of 100) with videos related to

Sort By:
Pageof 10
The Oncologist|July 18, 2023
Impact of Anti-EGFR Therapies on HER2-Positive Metastatic Colorectal Cancer: A Systematic Literature Review and Meta-Analysis of Clinical OutcomesTanios S Bekaii-Saab, Krzysztof Lach, Ling-I Hsu, et al.
Cancer Chemotherapy and Pharmacology|February 16, 2022
Cabozantinib with or without Panitumumab for RAS wild-type metastatic colorectal cancer: impact of MET amplification on clinical outcomes and circulating biomarkersJingquan Jia, Lauren Howard, Yingmiao Liu, et al.
Hematology Reports|October 25, 2024
Comprehensive Genomic Profiling in Non-Myeloid Hematologic Malignancies Identifies Variants That Can Alter Clinical PracticeChenyu Lin, Katherine I Zhou, Michelle F Green, et al.
Journal of Gastrointestinal Cancer|December 9, 2024
A Phase 2 study of Savolitinib in Patients with MET Amplified Metastatic Colorectal CancerJingquan Jia, Ashley Moyer, Melissa Lowe, et al.
Cancer|December 11, 2025
Pembrolizumab, Radiotherapy, and Chemotherapy in Neoadjuvant Treatment of Malignant Esophago-gastric Diseases (PROCEED): A single-arm phase 2 trialPooja Karukonda, Brian G Czito, Eileen Duffy, et al.
Clinical Lung Cancer|May 11, 2021
Predictive Value of Combining Biomarkers for Clinical Outcomes in Advanced Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint InhibitorsChester Kao, Eric Powers, Yuan Wu, et al.
Future Oncology (London, England)|August 3, 2022
Efficacy and safety of dilpacimab (ABT-165) versus bevacizumab plus FOLFIRI in metastatic colorectal cancer: a phase II studyJohn H Strickler, Antonio Cubillo, Jin-Tung Liang, et al.
Surgery|May 14, 2023
Hepatic artery infusion for unresectable colorectal cancer liver metastases: Palliation and conversionMohammad Y Zaidi, Daniel P Nussbaum, Shiaowen David Hsu, et al.
Cancer Research Communications|October 23, 2024
Association of Race and Ethnicity with Genomic Testing at a Comprehensive Cancer Center in North CarolinaClare Meernik, Frances Wang, Yadurshini Raveendran, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 13, 2019
Adjuvant Chemotherapy Improves Survival Following Resection of Locally Advanced Rectal Cancer with Pathologic Complete ResponseMegan C Turner, Jeffrey E Keenan, Christel N Rushing, et al.
Pageof 10